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Summary As an initial approach to optimize 8-aminolaevulinic acid (6-ALA)-induced photosensitization of tumours, we examined the
response of three enzymes of the haem biosynthetic pathway: 8-ALA dehydratase, porphobilinogen deaminase (PBGD) and ferrochelatase.
Only PBGD activity displayed a time- and dose-related increase in tumours after intravenous administration of 300 mg kg-1 6-ALA. The time
course for porphyrin fluorescence changes, reflecting increased production of the penultimate porphyrin, protoporphyrin IX (PPIX), showed a
similar pattern to PBGD. This apparent correlation between PBGD activity and porphyrin fluorescence was also observed in four cultured
tumour cell lines exposed to 0.1-2.0 mm 6-ALA in vitro. The increase in PBGD activity and PPIX fluorescence was prevented by the protein
synthesis inhibitor cycloheximide. As the apparent Km for PBGD was similar before and after 6-ALA, the increase in PBGD activity was
attributed to induction of enzyme de novo. These observations of an associated response of PBGD and PPIX imply that PBGD may be a rate-
limiting determinant for the efficacy of 6-ALA-induced photosensitization when used in photodynamic therapy.
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Haem is an essential prosthetic group in many critical cellular
proteins such as haemoglobin, cytochrome P450 and cyclo-
oxygenase (Abraham, 1991). Eight enzymes are involved in the
biosynthesis of haem, a process that occurs in two subcellular
compartments: the mitochondria and the cytosol. The first enzyme
in the haem pathway, mitochondrial 8-aminolaevulinic acid
synthase (8-ALA-S), forms 6-ALA from glycine and succinyl
CoA and is a target for the regulation of haem biosynthesis.
Feedback inhibition of8-ALA-S occurs when intracellularhaem is
present in excess (Ade, 1990).
The last step in the haem biosynthetic pathway, the insertion of
iron into PPIX to form haem, is catalysed by the mitochondrial
enzyme ferrochelatase (FC). In unperturbed systems, FC is regu-
lated by the availability ofiron and/or PPIX. Two ofthe metabolic
events that occur between 8-ALA-S and FC are catalysed by the
cytosolic enzymes 8-ALA dehydratase (8-ALA-D) and porpho-
bilinogen deaminase (PBGD). The dehydratase enzyme catalyses
the condensation of two 8-ALA molecules to form porpho-
bilinogen (PBG). It is the first enzyme that will metabolize the
administered 8-ALA. The next enzyme in haem biosynthesis,
PBGD, forms the tetrapyrole ring from four porphobilinogen
molecules (Abraham, 1991).
By providing the 8-ALA-S product, 8-ALA, the initial feedback
step has been circumvented and this approach has been exploited
for use in photodynamic therapy (PDT) of cancer (Kennedy and
Pottier, 1992; Grant et al, 1993; Cairnduffet al, 1994; Regula et al,
1995). Traditional PDT regimens consist ofthe systemic adminis-
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tration of a photosensitizer followed by an appropriate interval
to allow for its maximal accumulation in malignant tissue.
Subsequently, malignant lesions are exposed to light of an appro-
priate wavelength and damage is usually the result of a photo-
chemical reaction involving the conversion ofoxygen to its highly
toxic singlet state. However, prolonged skin photosensitivity
and/or lack of specificity for malignant tissue are undesirable
properties of many of the photosensitizers used in PDT
(Dougherty et al, 1978; Bown, 1990; Overholt et al, 1993; Fisher
et al, 1995). Recently, investigators have found that exogenous
administration of8-ALA to lesions can induce the accumulation of
protoporphyrin IX (PPIX) (Malik and Laguci, 1987; Shoenfeld et
al, 1994; Hua et al, 1995), an efficient photosensitizer (Kennedy et
al, 1990). In addition, there are reports that accumulation ofPPIX
is greater in malignant than normal tissues (Dailey and Smith,
1984; Abels et al, 1994; Kriegmeir et al, 1996). These factors
make 8-ALA-induced photosensitization an attractive alternative
to PDT regimens that use exogenous photosensitizers.
In this report, we investigated the effects of exogenous 8-ALA
administration on three selected enzymes in the haem biosynthetic
pathway, 6-ALA-D, PBGD and FC, and on the induction of
porphyrin fluorescence in R3230AC rodent mammary tumours in
vivo. We also investigated the effects of8-ALA on PBGD levels in
four tumour cell lines in vitro. Our results demonstrate that both
porphyrin fluorescence and PBGD activity increase in relation to
8-ALA dose and in a time-dependent manner in vivo, whereas 8-
ALA-D and FC activities do not. Cycloheximide, a protein
synthesis inhibitor, prevented the 8-ALA-induced increase in
PBGD activity and porphyrin fluorescence. There was also a simi-
larity between the 8-ALA-induced PBGD activity and porphyrin
fluorescence in the cultured cells we studied. Furthermore,
removal of 8-ALA from the culture medium resulted in a time-
related decrease in PBGD activity, changes that were similar to the
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marked decrease in porphyrin fluorescence. These findings imply
that PBGD could be a rate-limiting determinant for the amount of
PPIX synthesized when 8-ALA is administered for PDT.
MATERIALS AND METHODS
Chemicals and reagents
All chemicals and reagents were purchased from Sigma Chemical
(St Louis, MO, USA) unless otherwise noted. Cell culture media
and antibiotics were obtained from Grand Island Biological
(Grand Island, NY, USA). Fetal bovine serum (FBS) was
purchased from Atlanta Biologicals (Atlanta, GA, USA).
Porphobilinogen (PBG) was obtained from Porphyrin Products
(Logan, UT, USA).
Animals and tumours
The R3230AC mammary adenocarcinoma was maintained by
transplantation in the abdominal region of 100-120 g female
Fischer rats, using the sterile trocar technique described previously
(Hilf et al, 1965). The human mesothelioma tumour (H-MESO-1)
and the R3230AC tumour were studied as xenografts in nude
mice, according to the procedure of Gibson et al (1994). All
animals were cared for under the guidelines of the University
Committee on Animal Resources at the University of Rochester.
Administration of 8-ALA and cycloheximide to tumour-
bearing animals
Solutions of 8-ALA were freshly prepared by dissolving 30 mg of
8-ALA in 250g1 of sterile 0.9% sodium chloride. A dose of
300 mg of 8-ALA kg-' was administered i.v. to 120-135 g rats
bearing the R3230AC tumour. Cycloheximide was prepared by
dissolving 5.0 mg in 3.0 ml of sterile 0.9% sodium chloride. The
solution was administered i.p. to R3230AC tumour-bearing rats at
either 1.0 or 2.5 mg kg-' each day for 3 days, according to the
schedule ofHilfet al (1967). One hour after the last cycloheximide
injection, 8-ALA was administered as above.
Detection of porphyrin fluorescence in tissue
homogenates
The tissue concentrations of 8-ALA-induced porphyrins were
determined by measuring the fluorescence of tissue homogenates
at various times after 8-ALA injection. Animals were killed,
tissues excised, rinsed in 0.9% sodium chloride and frozen at
-800C until used for fluorescence measurements. Tissue samples,
approximately 0.1-0.15 g, were homogenized on ice in 2 x
volume 0.05 M phosphate buffer, pH 7.4 using a Polytron homo-
genizer (PCU 110, Brinkmann, Switzerland). Samples (10-120 1)
were transferred to a quartz cuvette containing 2 ml of 0.05 M
phosphate buffer, the suspension was mixed thoroughly with a
Pasteur pipette and the cuvette was positioned in a spectro-
fluorimeter (Fluorolog 2, SPEX Industries, Edison, NJ, USA).
This procedure produced a homogeneous suspension that was
quite transparent. The porphyrin fluorescence was linear over the
sample volume range (up to a sample volume of 120pl) used for
all the tissues studied. A 40gl aliquot was selected as the sample
size for these studies because it was in the linear range and the
fluorescence detected was adequate for analysis. Samples were
excited at 400 nm, and the fluorescence emission was scanned
from 600 nm to 720 nm, resulting in the appearance oftwo distinct
peaks positioned at 630 nm and 704 nm. Maximum fluorescence
intensity was detected at 630 nm, and this peak was selected for
measurement of the porphyrin content in tissues. The settings of
the fluorimeter were adjusted to obtain the optimum signal in the
least amount of time, <30 s, to avoid any possible photobleaching
of the porphyrin. Tissue concentrations were computed from the
fluorescence values obtained by a titration of a protoporphyrin
IX (PPIX) standard (Porphyrin Products, Logan, UT, USA).
Protoporphyrin IX was used as the standard as previous reports
demonstrated that PPIX is the major contributor to the fluores-
cence detected after exposure of cells to 8-ALA (Malik and
Lugaci, 1987; Kennedy and Pottier, 1992; Hua et al, 1995). Values
obtained in the present study were almost identical to those we
reported previously when porphyrin fluorescence was measured
on tissue extracts (Hua et al, 1995).
Measurement of enzyme activities in preparations from
R3230AC tumours
Activities of 8-ALA dehydratase (8-ALA-D), porphobilinogen
deaminase (PBGD) and ferrochelatase (FC) were measured to
determine whether administration of 8-ALA altered enzyme
activity. As each assay required isolation of different subcellular
compartments, tissues were divided before homogenization. The
assay for 8-ALA-D activity is a modification of a colorimetric
method using the absorption maximum ofEhrlich-PBG colour salt
at 556 nm (Sassa, 1982). Excised tissues were washed with cold
0.05 M sodium phosphate buffer (pH 7.4) containing 0.25 M
sucrose, and homogenized in 5 xvolume 0.01 M sodium phosphate
buffer (pH 7.4). The enzyme reaction mixture was freshly
prepared at final concentrations of8 mm8-ALA and 20 mmdithio-
threitol (DTT) in 0.05 M sodium phosphate buffer (pH 5.8). The
control mixture was prepared without 8-ALA. An aliquot
(10 pl) of tumour homogenate was added to 100 pl of either the
reaction mixture or the control mixture, and samples were incu-
bated in the dark for 1 h at 37°C. The reaction was terminated by
the addition of2.0 ml of6% trichloroacetic acid (TCA) containing
0.1 M mercury chloride. The mixture was centrifuged at lOOOg for
5 min. Supematants (1.0 ml) were transferred to separate test tubes
and equal amounts ofmodified Ehrlich's reagent were added. The
mixture was then incubated at room temperature for 10 min.
A difference spectrum was obtained by subtracting the 556 nm
absorbance ofthe control samples, i.e. those without8-ALA, from
the samples containing 8-ALA. The activity of 8-ALA-D is
expressed asgmol porphobilinogen mg-1 protein 1 h-'.
The assay for PBGD activity measures the absorbance of
uroporphyrin, formed after light-induced oxidation of uropor-
phyrinogen, which is the immediate product of the enzymatic
deamination reaction. The procedure is essentially described by
Grandchamp et al (1976). Briefly, tissues are homogenized
(1:5 w/v) in 0.05 M Tris-HCl (pH 7.4), centrifuged at lOOOg for
15 min and portions ofthe supematant containing 2 mg ofprotein
are incubated for 30 min at45°C in the dark with 1.0 ml ofporpho-
bilinogen at concentrations ranging from 0 to 500 JM. The reac-
tion is stopped by the addition of 2 ml of ethyl acetate/acetic acid
(3:1, v/v). The mixture is centrifuged at lOOOg and then exposed to
ambient light at room temperature for 15 min. The porphyrin
containing upper layer (1.6 ml) is transferred to a tube containing
1 ml of0.5 M hydrochloric acid, thoroughly mixed and centrifuged
British Journal ofCancer (1998) 77(2), 235-243 0CancerResearch Campaign 1998Photosensitization with 8-aminolaevulinic acid 237
at 2500g for 10 min. The lower layer is then transferred to a
cuvette, and the uroporphyrin absorption at 405 nm is measured.
The concentrations of uroporphyrin obtained from tissue prepara-
tions were calculated by reference to the values obtained from a
standard curve constructed with known amounts of uroporphyrin
subjected to the same extraction procedure. Activity is expressed
as pmol uroporphyrin formed per mg protein for 30 min.
The assay for ferrochelatase is based on the difference in
absorbance ofthe oxidized and reduced pyridine haemochromagen
products formed (DeMolina et al, 1989). Briefly, mitochondria are
prepared from tumour homogenates (Gibson and Hilf, 1983) and
incubated for 15 min at 37'C in the dark with a reagent mixture
containing final concentrations of mesoporphyrin IX (0-300 gM),
sodium succinate (10 mM), Tris-HCl (50 mm, pH 8.2) and mito-
chondrial suspension (approximately 10 mg protein ml-'). The
volume is adjusted to 2.88 ml with double distilled H20.
Subsequently, an aqueous solution of ferrous sulphate is added
with gentle mixing to obtain a final concentration of 625 gM, and
samples are incubated at 37°C for 30 min. Tubes are placed on ice
and 1 ml ofpyridine, 0.5 ml of 1 M sodium hydroxide and 1 ml of
water are added. Two 2.0-ml aliquots are removed and transferred
to separate 3.0 ml quartz cuvettes. Solid Na2S202 (1-5 mg) is
added to one cuvette, and 100gl of 3 mm potassium ferrocyanide
are added to the other. A difference spectrum is derived by subtrac-
tion of the absorbance at 531 nm, reduced sample, from the
absorbance of the oxidized sample obtained at 547 nm. The esti-
mated 8E of 21.7 x 103 M-1 cm-1 (Porra and Jones, 1963) was used
for the difference between the maximum absorbance at 547 nm
and the trough at 531 nm. The final data are expressed as,umol of
haem formed per mg mitochondrial protein for 30 min. This reac-
tion was linear over a range of5-20 mg mitochondrial protein and
for a 20- to 70-min incubation period after the addition of iron.
The spectra were obtained in a diode array spectrophotometer
(HP8452A, Hewlett Packard, Palo Alto, CA, USA).
Cells and culture conditions
The cell lines used were MCF-7, a human mammary tumour, a
human mesothelioma tumour (H-MESO-1) and R3230ACr and
R3230ACm, both established from the R3230AC rodent
mammary adenocarcinoma. The MCF-7 cell line was obtained
from the American Type Culture Collection (Bethesda, MD,
USA). Human mesothelioma tumours were initially propagated in
the flanks of nude mice (Ncr-nu) by subcutaneous injection of a
suspension (0.2 ml) containing 5 x 106 cells, which were obtained
from Mason Research Laboratories (Worcester, MA, USA). The
R3230AC rat mammary adenocarcinoma was maintained in
Fischer female rats as described above and cells (R3230ACr) were
cultured fromtumourhomogenates using the method ofHissin and
Hilf(1978). This tumour was also implanted subcutaneously in the
flanks ofnude mice using an incisional technique described previ-
ously (Gibson et al, 1994). Cells were cultured from these tumours
using the same method and are designated R3230ACm. All cell
lines were maintained in passage culture on 100 mm-diameter
polystyrene dishes (Costar, Cambridge, MA, USA) with 10 ml of
minimum essential medium (a-MEM) supplemented with 10%
fetal bovine serum (FBS), 50 units ml-1 penicillin G, 50 mg ml-1
streptomycin and 1.0 mg ml- fungizone ('complete a-MEM').
Only cells from passages 1-10 were used for experiments and a
stock of cells, passages 1-4, were maintained at - 860C to intiate
the experimental cultures. Cultures were maintained at 37°C in a
5% carbon dioxide humidified atmosphere (Forma Scientific,
Marietta, OH, USA). Passage was accomplished by removing the
culture medium and adding 1.0 ml of solution containing 0.25%
trypsin. Cells were then incubated for 2-5 min at 37°C to remove
them from the surface followed by seeding new culture dishes with
an appropriate number of cells in 10 ml of complete a-MEM. Cell
counts were performed using a particle counter (Model ZM,
Coulter Electronics, Hialeah, FL, USA).
Measurement of porphyrin fluorescence in cultured
cells
The extent of porphyrin biosynthesis that occurred in response to
incubation of cells with 8-ALA was determined by measuring the
fluorescence intensity of cell digests. Cells were seeded at a
density of 1.5 x 105 cells per well on 12-well plates and allowed to
reach 60-90% confluence, >3 x 105 cells per well. The 5-ALA
induced porphyrin fluorescence at cell densities greater than
3 x 105 cells per well did not change when the porphyrin content
was expressed on a per cell basis. The complete a-MEM was
removed, a-MEM minus FBS (a-MEM-FBS) plus various
concentrations of 5-ALA were added to the monolayers and incu-
bated for 4 h to assess the porphyrin biosynthesis. In parallel
experiments, 5-ALA was added at 0.5 mm for selected times to
determine the time course of appearance of fluorescence. All
monolayers were incubated in the dark under the conditions
described above. In one experimental protocol, medium containing
5-ALA was removed after a 3 h incubation period and replaced by
fresh medium containing 10% FBS. The cells were allowed to
incubate in the dark at 37°C for various periods. At the end of the
incubation periods, the medium was removed, monolayers were
washed once with 0.9% sodium chloride and 1.0 ml of 25%
Scintigest was added, which detached the cells within 5 min. The
cell-Scintigest suspension was transferred to 12 x 75 mm glass
test tubes, covered with parafilm and incubated at 37°C for
1 h in a water bath. The cell digests were stored at -20°C until
fluorescence was measured.
Fluorescence measurements were made on samples equilibrated
to room temperature and brought to a final volume of 2.0 ml with
1.0 ml of 25% Scintigest. Tubes were mixed vigorously and the
fluorescence determined as described above for tissue
homogenates. Background autofluorescence was determined in
cells that had not been exposed to 5-ALA, and these values were
subtracted from those of cells exposed to 5-ALA. Intracellular
porphyrin content was calculated by reference to the titrated PPIX
standard dissolved in Scintigest. Data are expressed as mols of
fluorescent porphyrin g-' cell protein. Cell protein content was
determined using the method ofLowry et al (1951).
Measurement of PBGD activity in cultured cells
Cells were cultured on 100 mm-diameter dishes or on 12-well
culture plates as described above. After the desired incubation
periods with 5-ALA, cells were removed by trypsinization (see
above) and transferred to 15-ml centrifuge tubes. Cells were
pelleted by centrifugation at IOOOg for 5 min. The supematant was
discarded and 1.0 ml ofdistilled deionized water was added to the
pellet and vigorously mixed. Cell suspensions were sonicated
using a Bronson Sonicator (Model 185) at a setting of 2 for 4 s.
Microscopic inspection demonstrated that > 90% ofthe cells were
disrupted by this procedure. The PBGD activity was measured as
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Figure 1 Time dependency of 6-ALA-induced effects on the activity of
enzymes in the haem biosynthetic pathway and fluorescent porphyrin levels
in R3230AC tumour tissue. Experimental conditions are described in
Materials and methods. The enzyme activities for 6-ALA-D (0), PBGD (0)
and FC (El) are expressed as per cent of control activity that was measured
in preparations obtained from untreated hosts. The asteriks on data points for
6-ALA-D and FC designate enzyme activities that are significantly different
from that measured in control, untreated samples. For comparison, porphyrin
fluorescence data (-- -) from our earlier study is included. Each data point
represents the mean of at least five separate experiments performed in
duplicate; bars are the s.e.m.
detailed above for cytosol preparations obtained from tumour
homogenates.
Statistical analyses
All statistical analyses were performed using the Student's t-test for
pairwise comparisons. A P-value < 0.05 was considered significant.
RESULTS
Effects of 6-ALA administration in vivo on enzyme and
porphyrin levels
Injection of 300 mg kg-' 6-ALA i.v. into R3230AC tumour-
bearing rats resulted in a time-dependent increase in porphyrin
fluorescence and in differential effects on the three haem biosyn-
thetic enzymes assayed in this study. The data depicted in Figure 1
demonstrate that the activities of 6-ALA-D at 4 h, and FC at 3 and
5 h after 6-ALA administration showed modest, but significant,
increases (designated by asteriks in Figure 1). In contrast, the
activity of PBGD in tumour tissue was significantly increased at
all times up to 6 h after 6-ALA administration. In both tumour and
liver tissue (data for liver not shown), we found that PBGD
activity was 6-ALA dose-dependent between 150 mg kg-' and
300 mg kg-' at 3 h after 6-ALA administration. The increase in
enzyme activity ofapproximately 1.5 or 2.5 times for 150 mg kg-1
or 300 mg kg-', respectively, above control tissue values was the
same in both liver and tumour tissue preparations. Interestingly,
the time course of change in porphyrin fluorescence in tumour
tissue samples after 6-ALA injection closely approximated the
pattern for the response of PBGD activity, reaching a peak at 3 h
after 6-ALA administration. At the 3 h time point, the amount
of porphyrin in tumour tissue was increased 100-fold over that
detected in control tissue (Figure 1, dashed line).
We performed experiments to ascertain whether the increase in
tumour PBGD activity was due to altered enzyme characteristics.
Assay of enzyme kinetics before and 3 h after injection of
300 mg kg-' 6-ALA indicated that the apparent K was similar. In
six separate experiments, the apparent Km ranged from 3.7 to 6.6gM
PBG for controls and from 3.1 to 6.5 gm PBG for tumours obtained
3 h after 6-ALA administration. However, the V1 differed with the
mean forcontrols at 366 pmol uroporphyrin mg-' protein per 30 min
(range 333-408) and a mean of735 pmol uroporphyrin mg-' protein
per 30 min (range 681-853) for tumour cytosols prepared 3 h after
administration of 300mg kg-' 6-ALA. These results suggest that
PBGD was induced by6-ALA administration in vivo.
Effects of cycloheximide on 6-ALA-induced enzyme
and porphyrin levels
Cycloheximide, frequently used to inhibitprotein synthesis, was
injected at 1.0 or 2.5 mg kg-' i.p. into R3230AC-bearing rats, daily
for 3 days, before administration of 6-ALA. The data from these
experiments are summarized in Table 1. At the lower dose of
1.0 mg kg-' cycloheximide given before 6-ALA, PBGD activity
approximated that ofcontrols, 410 vs 354 pmol uroporphyrin mg-'
protein per 30 min respectively. Thus, cycloheximide prevented
the expected doubling in PBGD activity seen in tumours 3 h after
animals were injected with 300 mg kg-' 6-ALA. Porphyrin levels
were similar in tumours from animals treated with this lower dose
of cycloheximide before 6-ALA administration, 421 vs 390 ng
fluorescent porphyrin mg-' protein respectively (Table 1). Daily
injections of cycloheximide at the higher dose of 2.5 mg kg-'
significantly decreased PBGD activity to a level of241 ± 22 pmol
uroporphyrin mg-1 protein per 30 min (Table 1). Likewise,
porphyrin levels in tumours from animals receiving the higher
dose ofcycloheximide and 300 mg kg-' 6-ALA were significantly
lower than tumours from animals treated with 6-ALA without or
with the lower dose ofcycloheximide (Table 1).
The modest increase in ferrochelatase resulting from 6-ALA
injection was completely prevented in animals injected with the
Table 1 Effects of cycloheximide administration on porphyrin and enzyme levels in R323OAc tumours
Cycloheximide &.ALA Porphyrin PBGD FC
(mg kg-') (mg kg-') (ng mg-' protein (pmol uroporphyrin (nmol haem
(per day/3 days) mg- protein per 30 min) mg-' protein per 30 min)
0 0 4.0 (0.7) 354 (5) 5.6 (0.12)
0 300 421 (18) 850 (29) 7.1 (0.25)
1.0 300 390 (14) 410 (11)
2.5 300 293 (20) 241 (22) 4.8 (0.23)
Cycloheximide was administered at designated doses on each day for 3 days before injection of6-ALA for 3 h. Animals were then killed and
tumours prepared for analysis (see Materials and methods). Each value represents the mean of at least five and up to 24 separate
determinations; numbers in parentheses are the s.e.m.
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Figure 2 Effects of various concentrations of 6-ALA on PBGD activity
measured in cultured tumour cell lines 3 h afterthe addition of 6-ALA. Assay
conditions are described in Materials and methods. The activity of PBGD was
measured in cells cultured from R3230ACr (0), R3230ACm (0),
mesothelioma (A) or MCF-7 (A) cells. Data are expressed as fmol
uroporphyrin formed per cell after 30 min of incubation. Each data point
represents the mean of at least four separate experiments performed in
duplicate, bars are the s.e.m.
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Figure 4 Levels of porphyrin fluorescence (0) and PBGD (0) activity in
R3230AC cells during exposure to 6-ALA in the culture medium. Assay
conditions are described in Materials and methods. Each data point
represents the mean of at least three separate experiments, bars are the
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Figure 3 Time-dependent induction of PBGD activity by 6-ALA in vitro.
R3230ACr (0), R3230ACm (0), mesothelioma (A) or MCF-7 (A) cells were
exposed to 0.5 mm 6-ALA for various times and PBGD activity determined.
Experimental details appear in Materials and methods. Data are expressed
as fmol uroporphyrin formed per cell after 30 min of incubation. Each data
point represents the mean of at least four separate experiments, bars are the
s.e.m.
higher dose ofcycloheximide, the levels approximating those seen
in tumours ofuntreated animals (controls). In fact, the level ofFC
activity after the higher cycloheximide dose regimen was lower
than that in untreated (control) animals, a pattern resembling the
results for PBGD.
Effects of varying the concentration of 6-ALA on PBGD
activity in vitro
We studied the effects of 6-ALA on PBGD activity in the same
cultured cell lines we had used previously to examine porphyrin
levels (Gibson et al, 1997). The initial experiments summarized
here were performed to seek out whether there was an association
between 6-ALA dose, porphyrin fluorescence and the activity of
PBGD in each of the cell lines. A number of conclusions can be
derived from the data shown in Fig. 2. The basal activity ofPBGD
in cells not exposed to 6-ALA was significantly higher in MCF-7
cells than that found in R3230ACr orR3230ACm cells, P < 0.025.
Further, the lowest PBGD activity was measured in cultured
mesothelioma cells and was significantly less than that assessed in
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Figure 5 Levels of porphyrin fluorescence and PBGD activity after removal
of 6-ALA from the culture medium. Cultured R3230AC cells propagated from
tumours borne on rats were exposed to 0.5 mm 6-ALA for 3 h after which 6-
ALA was removed from the medium. Levels of porphyrin fluorescence (0)
and PBGD activity (0) were determined as described in Materials and
methods. Each data point represents the mean of at least three separate
experiments performed in duplicate, bars are the s.e.m.
R3230AC cells (P<0.001). The descending rank order of basal
PBGD activity in these cell lines is: MCF-7 > R3230AC (rat) =
R3230AC (mouse) > mesothelioma. Despite the differences in
basal activities, the apparent Km for PBGD in R3230AC cells
cultured from tumours borne on rats and in mesothelioma cells
were similar, 12.5 ± 0.3 ,UM vs 15 ± 0.4gM PBG respectively.
The addition of 6-ALA to the medium led to a concentration-
related induction of PBGD activity. The PBGD activity in the
R3230ACr or R3230ACm cells, as well as in the MCF-7 cells,
increased significantly when 0.5 mM 6-ALA was present in the
medium, remaining at this maximum in the presence of2.0 mM 6-
ALA. In mesothelioma cells, a significant elevation in PBGD
activity was seen at 0.25 mm or higher concentrations of6-ALA,
with no further significant increases in activity when 6-ALA was
raised to 1.0 or 2.0 mm. These results indicate that maximal
activity of PBGD occurred under these conditions at levels of
0.5-1.0 mM 6-ALA.
Time course of6-ALA-induced PBGD activity in vitro
Having observed that a maximum induction ofPBGD activity was
reached by addition of 0.5 mm 6-ALA to the medium, we then
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assessed a time-course of6-ALA effects on PBGD by incubating
cells in culture with 0.5 mm 6-ALA and sampling at various times
up to 24 h. These results are shown in Figure 3. In all four cell
lines, PBGD activity was significantly increased 3 h after the addi-
tion of6-ALA. This increase in activity continued up to 24 h for
all the cell lines studied. In all cases, linear regression analysis
yielded correlation coefficients greater than 0.95. At 24 h, the fold
increase in PBGD activity over control was 3.2 times for MCF-7,
4.0 times for R3230ACr and R3230ACm cells, and 6.9 times for
mesothelioma cells. These data show that 0.5 mM 6-ALA is suffi-
cient to induce PBGD activity over time.
Comparison of porphyrin and PBGD levels during and
after exposure of cells to 6-ALA
The data displayed in Fig. 4 are a combination ofresults obtained
earlier for porphyrin content in R3230AC cells exposed to 0.5 mM
6-ALA over time (Gibson et al, 1997) and the present findings
for PBGD activity using the same experimental conditions. The
increase in both porphyrin fluorescence and PBGD activity is
linear over the 6-ALA exposure time studied, 8.6 x 10-8 mol fluo-
rescent porphyrin per g cell protein h-' and 80 fmol uroporphyrin
per 1 x 106 cells h-' respectively, with correlation coefficients of
r = 0.95 and r = 0.98 respectively. Upon removal of 6-ALA from
the culture medium and addition ofmedium containing 10% FBS,
porphyrin fluorescence remained constant for approximately 1 h
(Fig. 5). Subsequently, porphyrin fluorescence decreased dramati-
cally from 9.8 to 1.4 x 10-8 mol g-' cell protein at 24 h after
removal of6-ALA from the medium. This level ofporphyrin fluo-
rescence was similar to that observed in cells exposed to 6-ALA
for 30 min to 1 h. The activity of PBGD declined by approxi-
mately 30% at 1 h after removal of 6-ALA from the culture
medium and continued to decline, approaching control levels by
24 h. When 6-ALA was removed and cells were exposed to
medium without serum, intracellular porphyrin fluorescence did
not change significantly during the subsequent 24 h incubation
period (data not shown). In contrast, after removal of 6-ALA, the
reduction in PBGD activity occurred at the same rate whether
serum was present or absent in the culture medium.
DISCUSSION
The use ofintrinsic cellular processes to produce aphotosensitizer
for photodynamic therapy (PDT) is an intriguing alternative to
conventional PDT, which traditionally has used the systemic
administration of photosensitizing compounds. A more complete
understanding of the regulation ofthe haem biosynthetic pathway
and its response to exogenously administered 6-ALA would be
valuable for designing and optimizing future PDT protocols. One
aspect for optimization of treatment is the identification of the
steps in the haem biosynthetic pathway that regulate the produc-
tion ofphotosensitizing porphyrin moieties.
We recently examined the 8-ALA-induced synthesis of photo-
sensitizing porphyrins in vivo and in vitro (Hua et al, 1995; Gibson
et al, 1997). In one report (Hua et al, 1995), we found that the
induction of fluorescent porphyrins was 6-ALA dose and time
dependent in various rodent tissues and in the R3230AC rat
mammary adenocarcinoma. The amount ofporphyrin fluorescence
detected 3 h after systemic administration of 6-ALA was lowest in
the skin and muscle, 0.3 and0.36 ,ug porphyrin per g tissue, respec-
tively, and highest in the tumour and liver, 4.21 and 3.75 g
porphyrin per g tissue, respectively. Others have also reported
differential accumulation of fluorescent porphyrins in tissues after
exposure to 6-ALA. In two separate studies by Bown and
colleagues (1990), porphyrin levels were determined by microspec-
trofluorimetry in situ and by fluorescence in tissue extracts. They
found relatively high fluorescence in the mucosal layers of the
stomach and colon and much lower levels in the muscularis (Loh
et al, 1993). They also observed a significant difference in fluores-
cence between colon tumours and the surrounding normal tissue
in patients after the oral dose of6-ALA was increased from 30 to
60 mg kg-' (Regula et al, 1995). In another series of studies,
Kriegmeir and colleagues (1994, 1996) reported that in bladder
tumours at 4 h after intravesicle instillation of a 3% solution of
6ALA, porphyrin fluorescence was 20 times higher than that
detected in healthy urothelium (Baumgartner et al, 1993).
The disparity in 6-ALA-induced porphyrin levels in various
tissues prompted us to consider the possibility that the basal
activity of one or more enzymes in the haem pathway could corre-
late with the amount of porphyrin produced. We selected FC and
PBGD as initial candidates based on reports that suggested their
regulatory roles in the formation of PPIX and haem (Dailey and
Smith, 1984; Ades, 1990; Abraham, 1991). In our study, FC
activity in the tissues examined was similar, with the apparent Km
values of each being approximately 30 ,M mesoporphyrin. In
contrast, the apparent Km values for PBGD ranged from 26,uM to
13ljM PBG for the R3230AC tumour vs muscle tissue respec-
tively. There was no obvious relationship between the baseline
levels of FC or PBGD activity and the amount of porphyrin
produced in this selected spectrum of normal tissues and
R3230AC tumours after 6-ALA administration. As the apparent
Km values were not markedly altered, we asked whether the
activity of these enzymes in the haem pathway were altered by
administration of a pharmacological dose of 6-ALA, and if
enzyme activity were altered, whether that was related to the
detected changes in fluorescent porphyrins after 6-ALA injection.
We also measured 6-ALA-D as another potential regulatory
enzyme, as it is the initial enzyme in the haem pathway that metab-
olizes 6-ALA. Although we found that the activities of FC and
6-ALA-D were increased significantly, the modest increases
occurred only at isolated time points over the time course exam-
ined (Fig. 1). In contrast, PBGD activity rapidly increased with
time to a peak of 2.5 times control activity at 3 h after 6-ALA
administration. This peak of activity then declined, reaching
control levels 21 h later. We surmised from this response pattern
that the increase in activity was probably because of enzyme
induction by the 6-ALA or, perhaps, some other factor associated
with haem biosynthesis. Abraham (1991), using erythropoietin or
interleukin 3, concluded that PBGD was an inducible enzyme.
Ifthe increase in enzyme activity was induced by 6-ALA adminis-
tration, then pretreatment with the protein synthesis inhibitor,
cycloheximide, should interfere with the induction of PBGD
activity in tumours with 6-ALA administration. That, indeed, was
the case. A dose of 1.0 mg kg-' cycloheximide, daily for 3 days
before 6-ALA injection, resulted in PBGD activities that were
only 16% above control levels (see Table 1). As the apparent Km
values ofthe enzyme before and subsequent to 6-ALA administra-
tion were similar, these observations strongly suggest that the
increase in PBGD activity in vivo after 6-ALA administration was
due to enzyme synthesis de novo. However, additional studies are
underway to examine whether enzyme degradation is also affected
after 6-ALA administration.
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Curiously, porphyrin fluorescence in tumours from animals that
received the lower dose of cycloheximide plus &-ALA was not
lower than in tumours of animals given 6-ALA alone, a result in
agreement with Washbrook et al (1997). They reported that, in
cultured epithelial cells treated with cycloheximide before 6-ALA,
despite cell protein levels being reduced by 50%, porphyrin levels
remained similar to those in cells treated with 6-ALA alone.
Hence, the changes in porphyrin fluorescence and PBGD activity
under these circumstances implicates a regulatory role of PBGD
leading to the increased accumulation in fluorescent porphyrins.
We extended our studies in vivo to studies in vitro which exam-
ined the effects of 6-ALA exposure on PBGD activity in four
cultured tumour cell lines, relating this to results obtained earlier
for 6-ALA-induced changes in cellular porphyrin content (Gibson
et al, 1997). Basal levels of PBGD activity followed the same
descending rank order as porphyrin accumulation for these cell
lines, MCF-7 > R3230AC rat = R3230AC mouse > mesothelioma.
There was also a 6-ALA concentration-related increase in PBGD
activity that plateaued at different levels according to the cell line
studied. The cessation of linear increase was similar to that
observed for the 6-ALA induced porphyrin fluorescence.
Interestingly, the similarity between the increase in porphyrin fluo-
rescence and PBGD activity was also evidentduring a 24-h 6-ALA
exposure period of R3230ACr cells in culture (Fig. 4).
Replacement of the 6-ALA-containing medium with a serum-
containing medium without 6-ALA resulted in a similar pattern of
reduction forboth porphyrin fluorescence and PBGD activity (Fig.
5). The estimate ofPBGD turnover rate ofapproximately 3 h also
suggests an inducible enzyme, a property often associated with
enzymes that have regulatory roles in metabolism.
From these data, we inferthat PBGD may have aregulatory role
in the 6-ALA induced increase in porphyrin levels. Our findings
would support those of Healy et al (1981), who proposed that
PBGD was the rate-limiting enzyme for hepatic conversion of 5-
ALA to protoporphyrin when 6-ALA is in excess. A number of
other reports have focused on the possibility that a reduced or
defective FC, relative to other enzymes in the pathway, could
account for an increased accumulation of porphyrins in many
malignant tissues (Dailey and Smith, 1984; van Hillegersberg et al,
1992). We, however, previously have found no significant differ-
ence in FC kinetics among various tissues, including the R3230AC
rat mammary tumour (Hua et al, 1995). Together, these reports
signify the need to define the role ofall ofthe enzymes in the haem
biosynthetic pathway to understand better the mechanisms
involved in 6-ALA based PDT.
In conclusion, considerable efforts have been made to optimize
the outcome ofPDT. In the case ofPhotofrin, as well as photosen-
sitizers designated as 'second generation', investigations ofdosing
have used traditional pharmacokinetics to define times of
maximum sensitizer concentration in tumours, maximum tumour-
normal tissue ratios, toxicity, metabolism, etc., as well as explo-
ration of irradiation schema related to total fluence and fluence
rates (Gomer, 1991; Henderson and Dougherty, 1992; Fisher et al,
1995). Unlike systemic administration of a photosensitizer, opti-
mization of 6-ALA induction of protoporphyrin IX represents a
different challenge because the photosensitizer is a product of a
biosynthetic pathway that evolved to form haem, a non-photosen-
sitizing end product. By providing excess 6-ALA, the initial feed-
back control step, 6-ALA-S, is circumvented. However, much less
knowledge of the regulatory control of the enzymatic steps
between 6-ALA and haem is available, and such information is
essential ifone is to devise protocols to achieve optimal photosen-
sitization. The data presented here suggest a regulatory role for
PBGD owing to its induction by 8-ALA administration, seen as a
rapid increase in activity (approximately 2.5 times), followed by a
a rapid decline. The increase in activity was accompanied by an
increase in tissue porphyrin fluorescence, both of which were
prevented by pretreatment with cycloheximide. This behaviour is
in contrast to that of ALA-D and FC under the same experimental
conditions. Hence, if PBGD assumes the next rate-limiting step
after 8-ALA-S in the haem biosynthetic pathway, the role of
PBGD in the regulation of production of photosensitizing
porphyrins will require further elucidation. Schemes for opti-
mizing the production of a photosensitizer in this multistep
pathway will probably be different in normal tissues and in a
variety oftumours ofdifferent origin particularly as the levels and
activities ofthe enzymes are not identical in these different tissues.
It is also conceivable that, if PBGD is a rate-limiting step,
measurement of its basal activity in tissue samples may provide
insight into the potential efficacy of PDT for that tissue. Ongoing
experiments will seek to resolve some ofthese questions.
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